Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 166 across all filing types
Latest filing 2025-07-21 M&A Activity
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
MedCaps Affärsområde Specialistläkemedel fullföljer förvärvet av XGX Pharma
M&A Activity Classification · 1% confidence The document is a short press release (1086 characters) dated July 21, 2025, announcing the completion of an acquisition ('fullföljer förvärvet av XGX Pharma'). This relates to corporate activity involving mergers or acquisitions. Based on the definitions, the most specific category for announcing a merger or takeover proposal/completion is 'M&A Activity' (Code: TAR). It is not a general regulatory filing (RNS) because a more specific category exists, and it is not an announcement of a report (RPA) but an announcement of a business transaction.
2025-07-21 Swedish
MedCaps Affärsområde Specialistläkemedel förvärvar XGX Pharma
M&A Activity Classification · 1% confidence The document is a press release dated June 25, 2025, announcing that MedCap's subsidiary is acquiring XGX Pharma. This involves a significant transaction, including purchase price details and conditions for closing (FDI approval, expected Q3 2025 completion). This type of announcement, detailing a merger or acquisition proposal, directly corresponds to the M&A Activity category (TAR). It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate action.
2025-06-25 Swedish
Ändring av antal aktier och röster i MedCap AB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short press release dated May 30, 2025, titled "Ändring av antal aktier och röster i MedCap AB" (Change in the number of shares and votes in MedCap AB). It explicitly states that due to the exercise of warrants, the total number of shares and votes has increased, and it provides the new total share capital. This directly relates to a change in the company's capital structure or share count. This aligns best with the 'Share Issue/Capital Change' definition (Code: SHA). It is not an announcement of a report (RPA/RNS), nor is it a general regulatory filing (RNS) given the specific nature of the content.
2025-05-30 Swedish
Återköp av aktier i MedCap 22 maj 2025 - 27 maj 2025 – återköpsprogram avslutat
Transaction in Own Shares Classification · 1% confidence The document text consists almost entirely of tabular data showing transaction records, including 'Instrument' (MCAP.ST), 'Fill volume', 'Gross price', 'Trade ID', and 'Execution Venue' (XSTO). This structure strongly suggests a report detailing trading activity or insider transactions. Since the data points are specific trades and volumes, and the document is relatively short (under 5,000 characters based on the provided snippet, although the metadata suggests 28k total, the content is clearly transactional), it aligns best with reports concerning share transactions. The definition for 'Director's Dealing' (DIRS) covers personal share transactions by directors, and while this looks like general market trade data, in the context of corporate filings, detailed transaction logs often relate to insider activity or significant share movements. However, given the format is raw trade data (Buy/Sell indicators 'B', timestamps, venue XSTO), it most closely resembles a regulatory filing reporting specific transactions. If this were a director's dealing report, it would typically name the director. Since it is raw trade data, and there is no explicit mention of a director or management, the most appropriate general category for transaction reporting that isn't a capital change (SHA) or share repurchase (POS) is often captured under general regulatory disclosures. Given the options, and the lack of context identifying this as a director's trade, it is most likely a notification of significant share ownership change (MRQ) or a general regulatory filing (RNS). Since it is raw trade data rather than a formal notification summary, RNS (Regulatory Filings) is the safest fallback for raw transactional data that doesn't fit the specific insider/repurchase categories without further context. If this were a director's dealing report, it would be DIRS, but without that context, RNS is the fallback for miscellaneous regulatory data.
2025-05-27 English
Återköp av aktier i MedCap 15 maj 2025 – 21 maj 2025
Director's Dealing Classification · 1% confidence The document text consists almost entirely of tabular data showing transaction details, including Instrument (MCAP.ST), volume, price, trade ID, and execution venue (XSTO). This structure strongly suggests a record of trading activity or insider transactions. Since the data shows transactions involving the instrument 'MCAP.ST' and includes columns like 'Instrument', 'volume', and 'Trade ID', it is highly indicative of a Director's Dealing report or a notification of significant share transactions. Given the format, which looks like a regulatory filing snippet detailing personal share transactions by executives or directors, the most appropriate classification is Director's Dealing (DIRS). It is not a comprehensive financial report (10-K, IR, ER) or a general announcement (RPA, RNS).
2025-05-21 English
Återköp av aktier i MedCap 8 maj 2025 – 14 maj 2025
Transaction in Own Shares Classification · 1% confidence The provided document text consists almost entirely of tabular data showing transaction records, including instrument codes (MCAP.ST), fill volumes, gross prices, execution timestamps (e.g., 20250508 09:36:55.760953), and trade IDs. This structure is characteristic of market data feeds, trade confirmations, or regulatory transaction reports, but it does not align with the definitions provided for standard corporate filings like 10-K, ER, IR, or AGM-R. Since the content is raw transaction data and does not fit any specific corporate disclosure category (like Director's Dealing, Major Shareholding, or Capital Change), the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous regulatory or market data submissions that don't fit the primary definitions. The document length is substantial (41k chars), suggesting it is the data itself, not just an announcement.
2025-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.